Avenue Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 17-11-2024
- Paid Up Capital ₹ 0.50 M
as on 17-11-2024
- Company Age 15 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 4.50 Cr
as on 17-11-2024
- Revenue -57.24%
(FY 2023)
- Profit 70.68%
(FY 2023)
- Ebitda -167.33%
(FY 2023)
- Net Worth 7.83%
(FY 2023)
- Total Assets 1.02%
(FY 2023)
About Avenue Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.50 M.
The company has closed loans amounting to ₹4.50 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Krishna Sachan, Pradip Sachan, Arun Sachan, and One other member serve as directors at the Company.
- CIN/LLPIN
U51909DL2009PTC191735
- Company No.
191735
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Jun 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Avenue Pharma?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Krishna Sachan  | Director | 30-Jun-2009 | Current |
| Pradip Sachan | Director | 30-Jun-2009 | Current |
| Arun Sachan | Director | 08-Apr-2016 | Current |
| Aman Sachan | Director | 23-Dec-2016 | Current |
Financial Performance and Corporate Structure Insights of Avenue Pharma.
Avenue Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 57.24% decrease. The company also saw a substantial improvement in profitability, with a 70.68% increase in profit. The company's net worth moved up by a moderate rise of 7.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Avenue Pharma?
In 2023, Avenue Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Aman Drugs Private LimitedActive 19 years 10 monthsKrishna Sachan, Pradip Sachan and 1 more are mutual person
Docplus Technologies Private LimitedActive 5 years 9 daysKrishna Sachan and Aman Sachan are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 04 Jul 2017 | ₹4.50 Cr | Satisfied |
How Many Employees Work at Avenue Pharma?
Avenue Pharma has a workforce of 1 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Avenue Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Avenue Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
